» Articles » PMID: 38494253

SARS-CoV-2 Omicron Spike Shows Strong Binding Affinity and Favourable Interaction Landscape with the TLR4/MD2 Compared to Other Variants

Overview
Specialty Biotechnology
Date 2024 Mar 17
PMID 38494253
Authors
Affiliations
Soon will be listed here.
Abstract

Emergences of SARS-CoV-2 variants have made the pandemic more critical. Toll-like receptor 4 (TLR4) recognizes the molecular patterns of pathogens and activates the production of proinflammatory cytokines to restrain the infection. We have identified a molecular basis of interaction between the Spike and TLR4 of SARS-CoV-2 and its present and past VOCs (variant- of concern) through in silico analysis. The interaction of wild type Spike with TLR4 showed 15 number hydrogen bonds formation. Similarly, the Alpha variants' Spike with the TLR4 has illustrated that 14 hydrogen bonds participated in the interaction. However, the Delta Spike and TLR4 interaction interface showed that 17 hydrogen bonds were formed during the interaction. Furthermore, Omicron S-glycoprotein and TLR4 interaction interface was depicted (interaction score: -170.3), and 16 hydrogen bonds were found to have been formed in the interaction. Omicron S-glycoprotein shows stronger binding affinity with the TLR4 than wild type, Alpha, and Delta variants. Similarly, the Alpha Spike shows higher binding affinity with TLR4 than the wild type and Delta variant. Now, it is an open question of the molecular basis of the interaction of Spike and TLR4 and the activated downstream signaling events of TLR4 for SARS-CoV-2 and its variants.

Citing Articles

Recent Advances in Immunological Landscape and Immunotherapeutic Agent of Nipah Virus Infection.

Chakraborty C, Saha S, Bhattacharya M Cell Biochem Biophys. 2024; 82(4):3053-3069.

PMID: 39052192 DOI: 10.1007/s12013-024-01424-4.


In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants.

Kircheis R Int J Mol Sci. 2024; 25(10).

PMID: 38791489 PMC: 11121871. DOI: 10.3390/ijms25105451.


BSA Binding and Aggregate Formation of a Synthetic Amino Acid with Potential for Promoting Fibroblast Proliferation: An In Silico, CD Spectroscopic, DLS, and Cellular Study.

Simonyan H, Palumbo R, Petrosyan S, Mkrtchyan A, Galstyan A, Saghyan A Biomolecules. 2024; 14(5).

PMID: 38785986 PMC: 11118884. DOI: 10.3390/biom14050579.

References
1.
Callaway E . Heavily mutated Omicron variant puts scientists on alert. Nature. 2021; 600(7887):21. DOI: 10.1038/d41586-021-03552-w. View

2.
Otto S, Day T, Arino J, Colijn C, Dushoff J, Li M . The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Curr Biol. 2021; 31(14):R918-R929. PMC: 8220957. DOI: 10.1016/j.cub.2021.06.049. View

3.
Kawai T, Akira S . The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010; 11(5):373-84. DOI: 10.1038/ni.1863. View

4.
Davies N, Abbott S, Barnard R, Jarvis C, Kucharski A, Munday J . Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021; 372(6538). PMC: 8128288. DOI: 10.1126/science.abg3055. View

5.
Tchesnokova V, Kulasekara H, Larson L, Bowers V, Rechkina E, Kisiela D . Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants. J Clin Microbiol. 2021; 59(11):e0092121. PMC: 8525575. DOI: 10.1128/JCM.00921-21. View